BIXT stock forecast, quote, news & analysis

Bioxytran Inc is a clinical stage pharmaceutical company developing platform technologies in the fields of Glycovirology, Hypoxia and Degenerative Diseases to eliminate viruses and prolong lifespan using carbohydrate drug design... Show more

Get AI intraday signals

BIXT

Setup

Daily Signal:

Description

Gain/Loss:

A.I.Advisor

published price charts

Intraday

View AI-Driven Trading for BIXT

Interact to see
Advertisement

A.I.Advisor

a Summary for BIXT with price predictions

May 22, 2026

Momentum Indicator for BIXT turns negative, indicating new downward trend

BIXT saw its Momentum Indicator move below the 0 level on May 20, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 88 similar instances where the indicator turned negative. In of the 88 cases, the stock moved further down in the following days. The odds of a decline are at .

Technical Analysis (Indicators)

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BIXT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .